Clinical trial to evaluate the efficacy and safety of E-52862 ( 400 mg) by oral route, in patients with post herpetic neuralgia (PHN).

Registry ID

EUCTR2012-000399-41

Source registry

EUCTR

Status

Prematurely Ended

Phase

PHASE2

Sponsor

Laboratorios del Dr. Esteve. S.A.

Start date

2012-07-23

Last update

2026-08-16

Conditions

• Postherpetic Neuralgia

Summary

The primary objective of this study is to assess the analgesic efficacy of E-52862 in subjects with moderate to severe postherpetic neuralgia

Locations

• , , Spain

Related clinical trials

• Y-4 to Treat the Postherpetic Neuralgia
• The Analgesic Efficacy and Safety of Venlafaxine for Prevention of Postherpetic Neuralgia in Patients With Acute Herpes Zoster
• Erector Spinae Plane Block Versus Transcutaneous Radiofrequency in Postherpetic Neuralgia
• Efficacy of Transcutaneous Pulsed Radiofrequency in Postherpetic Neuralgia
• Clinical Trial of the Safety and Efficacy of Peripheral Nerve Stimulation in the Treatment of Peripheral Neuropathic Pain.
• The Effectiveness of Ultra-Sound Guided Erector Spinae Block With Betamethasone for Management of Truncal Chronic Post Herpetic Neuralgia.

View on source registry